From: Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle
NP type and size | Protein investigated | Protein mol. wt. and size nm (if provided) | Change in protein structure | Analytical technique | Observations | Ref |
---|---|---|---|---|---|---|
ZnO NPs (25Â nm) | Vibrio cholera Tox r | 32.5Â kDa | Yes | CD | NP-protein complex susceptible to denaturation | [40] |
ZnO NPs (N/A) | BSA | 66Â kDa | Yes | CD | Minor conformational changes, secondary structure retained | [31] |
ZnO NPs (N/A) | BSA | 66Â kDa | Yes | FTIR | Minor conformational changes in secondary structure | [42] |
TiO2 NPs (20Â nm) | Tubulin | 55kda | Yes | FS | Protein polymerization affected | [30] |
SiO2 NPs (~40Â nm) | BSA | 66Â kDa | Yes | RS | BSA and lactoperoxidase bound irreversibly | [33] |
Hen egg lysozyme | 14.3Â kDa | No | ||||
RNASe A | 13.7Â kDa | No | ||||
Lactoperoxidase | 77.5Â kDa | Yes | ||||
SiO2 NPs (6,9,15Â nm) | Human Carbonic anhydrase | 29Â kDa | Yes | NMR | Protein activity was retained | [4] |
Alumina and hydroxyapatite particles (100-300 nm) | BSA | 66 kDa 8 × 8 × 3 | Yes | FTIR | Loss in α-helical structure | [43] |
Hen egg lysozyme | 14.3 kDa 4.6 × 3 × 3 | Yes | ||||
Bovine serum fibrinogen | 350 kDa 6 × 6.5 × 45 | Yes | ||||
Gold (45Â nm) | BSA | 66Â kDa | Yes | CD | Conformational change was dose dependent | [28] |
Gold (5-100Â nm) | Albumin | 67Â kDa | Yes | CD and FS | Minor conformational changes observed | [27] |
Fibrinogen | 340Â kDa | Yes | ||||
É£-globulin | 120Â kDa | Yes | ||||
Histone H3 | 15Â kDa | Yes | ||||
Insulin | 5.8Â kDa | Yes | ||||
Gold (7-22 nm) | Human Fibrinogen | 340 kDa 45 × 5 | Yes | CD | Unfolding induced immune response in THP-1 cells | [35] |
SPIONs (5-10Â nm) | Transferrin | 80Â kDa | Yes | CD | Irreversible interaction | [32] |
SWCNTs (N/A) | Horse radish peroxidase | 44Â kDa | No | CD | NP-protein complexes retained enzymatic activity | [34] |
Subtilisin Carlsberg | 39Â kDa | No | ||||
Chicken egg white lysozyme | 14.3Â kDa | No |